Clinical Trials Directory

Trials / Unknown

UnknownNCT04474951

Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

Food Supplements to Control Signs and Symptoms Induced by Cancer Therapies

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to evaluate the impact of food supplements (herbal remedies) on sign and symptoms induced by cancer therapies: Nettle will be administered for improvement of anemia and fatigue; Peppermint will be administered for improvement of nausea. Secondary aims of the trial are to evaluate the impact of these supplements on the quality of life and to evaluate their tolerability profile.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStinging NettleEligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of anemia.
DIETARY_SUPPLEMENTStinging NettleEligible patients will take 40 drops TID of Fluid Extract of Stinging Nettle for control of fatigue.
DIETARY_SUPPLEMENTPeppermintEligible patients will take 40 drops TID of Fluid Extract of Peppermint for control of nausea.

Timeline

Start date
2019-06-20
Primary completion
2021-03-01
Completion
2021-09-01
First posted
2020-07-17
Last updated
2020-07-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04474951. Inclusion in this directory is not an endorsement.